Managing of screening-detected sub-solid nodules—a European perspective

Por Ricciardi, Sara, Booton, Richard, Petersen, Renè Horsleben, Infante, Maurizio, Scarci, Marco, Veronesi, Giulia, Cardillo, Giuseppe
Publicado no Transl Lung Cancer Res (2021)

Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis

Por Chakravarti, Nitin, Prieto, Victor G.
Publicado no Transl Lung Cancer Res (2015)

Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way...

Por Pilotto, Sara, Molina-Vila, Miguel Angel, Karachaliou, Niki, Carbognin, Luisa, Viteri, Santiago, González-Cao, Maria, Bria, Emilio, Tortora, Giampaolo, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2015)

Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

Por Pilotto, Sara, Carbognin, Luisa, Karachaliou, Niki, Garassino, Marina, Cuppone, Federica, Petraglia, Sandra, Rosell, Rafael, Tortora, Giampaolo, Bria, Emilio
Publicado no Transl Lung Cancer Res (2015)

Gefitinib in non-small-cell lung cancer—an old lesson new re-visited

Por Dempke, Wolfram C. M.
Publicado no Transl Lung Cancer Res (2013)

Managing screening-detected subsolid nodules—the Asian perspective

Por Sato, Masaaki, Yang, Shun-Mao, Tian, Dong, Jun, Nakajima, Lee, Jang-Ming
Publicado no Transl Lung Cancer Res (2021)

The person behind the nodule: a narrative review of the psychological impact of lung cancer screening

Por Quaife, Samantha L., Janes, Samuel M., Brain, Kate E.
Publicado no Transl Lung Cancer Res (2021)

Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)

Por Ku, Bo Mi, Heo, Mi Hwa, Kim, Joo-Hang, Cho, Byoung Chul, Cho, Eun Kyung, Min, Young Joo, Lee, Ki Hyeong, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Kim, Tae Jung, Lee, Ho Yun, Kim, Hojoong, Lee, Kyung-Jong, Ahn, Myung-Ju
Publicado no J Pathol Transl Med (2018)

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)

Por Okajima, Masaaki, Miura, Satoru, Watanabe, Satoshi, Tanaka, Hiroshi, Ito, Kazuhiko, Ishida, Takashi, Makino, Masato, Iwashima, Akira, Matsumoto, Naoya, Sato, Kazuhiro, Ichikawa, Kosuke, Abe, Tetsuya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Publicado no Transl Lung Cancer Res (2021)

Validation of multivariable lung cancer risk prediction models for the personalized assignment...

Por González Maldonado, Sandra, Hynes, Lucas Cory, Motsch, Erna, Heussel, Claus-Peter, Kauczor, Hans-Ulrich, Robbins, Hilary A., Delorme, Stefan, Kaaks, Rudolf
Publicado no Transl Lung Cancer Res (2021)

Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer

Por Zhang, Zhonghan, Zhang, Yang, Luo, Fan, Ma, Yuxiang, Fang, Wenfeng, Zhan, Jing, Li, Su, Yang, Yunpeng, Zhao, Yuanyuan, Hong, Shaodong, Zhou, Ting, Zhang, Yaxiong, Zhao, Shen, Huang, Yan, Zhao, Hongyun, Zhang, Li
Publicado no Clin Transl Med (2020)

Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database

Por Anggondowati, Trisari, Ganti, Apar Kishor, Islam, K. M. Monirul
Publicado no Transl Lung Cancer Res (2020)

Empiric Radiotherapy for Lung Cancer Collaborative Group multi-institutional evidence-based...

Por Berman, Abigail T., Jabbour, Salma K., Vachani, Anil, Robinson, Cliff, Choi, J. Isabelle, Mohindra, Pranshu, Rengan, Ramesh, Bradley, Jeffrey, Simone, Charles B.
Publicado no Transl Lung Cancer Res (2019)

Functional promoter rs189037 variant of ATM is associated with decrease in lung diffusing capacity after irradiation for non–small-cell lung cancer

Por Lopez Guerra, Jose Luis, Song, Yi-Peng, Nguyen, Quynh-Nhu, Gomez, Daniel R., Liao, Zhongxing, Xu, Ting
Publicado no Chronic Dis Transl Med (2018)

Impact of one-week preoperative physical training on clinical outcomes of surgical lung cancer patients with limited lung function: a randomized trial

Por Lai, Yutian, Wang, Xin, Zhou, Kun, Su, Jianhuan, Che, Guowei
Publicado no Ann Transl Med (2019)

Clinical observation of Pemetrexed first-line treatment in advanced non-squamous lung cancer or non...

Por Sha, Zhou, He, Jian-Bo, Jiang, Qinling, Xu, Linlin, Hu, Liyang, Liang, Zibin, Li, Tin, Lin, Zhong, Yu, Qitao, Pei, Xiaofeng, Lv, Weize
Publicado no Ann Transl Med (2020)

Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer

Por Huynh, Caroline, Walsh, Logan A., Spicer, Jonathan D.
Publicado no Transl Lung Cancer Res (2021)

B cells in lung cancer—not just a bystander cell: a literature review

Por Leong, Tracy L., Bryant, Vanessa L.
Publicado no Transl Lung Cancer Res (2021)

Antiproliferative effect of Toona sinensis leaf extract on non–small-cell lung cancer

Por Yang, Chih-Jen, Huang, Yu-Jung, Wang, Cheng-Yuan, Wang, Pei-Hui, Hsu, Hseng-Kuang, Tsai, May-Jywan, Chen, Yu-Chu, Bharath Kumar, V., Huang, Ming-Shyan, Weng, Ching-Feng
Publicado no Transl Res (2010)

PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer

Por Bang, Andrew, Schoenfeld, Jonathan D., Sun, Alexander Y.
Publicado no Transl Lung Cancer Res (2019)